Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.
Bistervels IM, Buchmüller A, Wiegers HMG, Ní Áinle F, Tardy B, Donnelly J, Verhamme P, Jacobsen AF, Hansen AT, Rodger MA, DeSancho MT, Shmakov RG, van Es N, Prins MH, Chauleur C, Middeldorp S; Highlow Block writing committee; Highlow Investigators. Bistervels IM, et al. Among authors: buchmuller a. Lancet. 2022 Nov 19;400(10365):1777-1787. doi: 10.1016/S0140-6736(22)02128-6. Epub 2022 Oct 28. Lancet. 2022. PMID: 36354038 Clinical Trial.
Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study Group.
Leroyer C, Bressollette L, Oger E, Mansourati J, Chèze-Le Rest C, Nonent M, Buchmuller A, Tardy B, Decousus H, Parent F, Simonneau G, Juste K, Ill P, Abgrall JF, Clavier J, Mottier D. Leroyer C, et al. Among authors: buchmuller a. Haemostasis. 1998 Mar-Apr;28(2):70-7. doi: 10.1159/000022415. Haemostasis. 1998. PMID: 10087431 Clinical Trial.
[New oral anticoagulants in the treatment of venous thromboembolism].
Bertoletti L, Lega JC, Moulin N, Buchmuller A, Mismetti P, Decousus H. Bertoletti L, et al. Among authors: buchmuller a. Presse Med. 2013 Sep;42(9 Pt 1):1232-8. doi: 10.1016/j.lpm.2013.06.001. Epub 2013 Jul 19. Presse Med. 2013. PMID: 23876652 French.
Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
Bleker SM, Buchmüller A, Chauleur C, Ní Áinle F, Donnelly J, Verhamme P, Jacobsen AF, Ganzevoort W, Prins M, Beyer-Westendorf J, DeSancho M, Konstantinides S, Pabinger I, Rodger M, Decousus H, Middeldorp S. Bleker SM, et al. Among authors: buchmuller a. Thromb Res. 2016 Aug;144:62-8. doi: 10.1016/j.thromres.2016.06.001. Epub 2016 Jun 3. Thromb Res. 2016. PMID: 27289488 Clinical Trial.
35 results